It’s easy to see how early-stage tech VC investing can make arguably the largest returns. If you get it right investing in a disruptive business like WhatsApp or Alibaba can generate huge exits: a whopping $22Bn and $25Bn respectively (Sequoia Capital turned $60 million into $3 billion thanks to WhatsApp). And not just in The…

Investors are looking for alternative strategies and techniques to improve earnings and reduce risk. We will look at how businesses can optimise their business model and gain traction for long-term sustainable growth – for the investor this means less risk, less capital needed and plenty of added value. Who is the event for? This event…

Gene editing is one of hottest areas of life sciences. Many scientists are working towards using CRISPR technology to provide genetic solutions to conditions by literally editing the DNA in the genes. Desktop Genetics provides gene editing software (SaaS and on-prem) to make CRISPR gene editing easy and cost-effective. With their platform, DESKGEN, scientists can…

Boundary Capital has announced its latest investment in Toxibact, a disruptive technology which has the potential to kill a wide range of microorganisms including bacteria and fungi with little prospect of them being able to develop resistance. Toxibact has a novel potential antimicrobial therapy for the treatment of all bacteria – both ‘gram positive’ and…

Boundary Capital has announced its latest investment in AB-Polyblok, a revolutionary technology which has the potential to treat, and potentially partially reverse, the effects of Alzheimer’s Disease. AB-Polyblock has a novel potential drug therapy for the treatment of Alzheimer’s Disease. The drug was conceived and developed after independent, private research. Alzheimer’s Disease is the largest…

Boundary Capital is featured in this month’s issue of EIS Magazine discussing the pros and cons of Crowdfunding… Crowdfunding: Where Angels Fear to Tread? Dan Somers, Managing Partner at London-based Boundary Capital Partners, says that crowdfunding is a phenomenon of our age: “Whilst most crowdfunding is debt-based, UK equity crowdfunding (our focus here) rose from…

Avoiding the follow on? Boundary Capital Partners and Olswang invite you to hear from investors and entrepreneurs who have successfully navigated multiple investment rounds. Tuesday 8th March 2016 at OLSWANG 90 High Holborn, London, WCIV 6XX from 6:30pm. RSVP at rsvp@boundarycapital.com

Two industry leaders have been appointed partners at early-stage venture capital firm Boundary Capital. Dr Adrian Parton MBE and Grant Hawthorne are both key influencers in their respective fields of biotechnology and investment. The appointments mark an increase in UK investments made by Boundary Capital in 2015 and the launch of their new SEIS fund…

Boundary Capital has announced its latest investment in LawyerFair, a disruptive legal services platform aimed at Small and Medium-Sizes Enterprises (SMEs). LawyerFair is an early-stage technology company already changing the way legal services are procured to provide value to both SMEs and law firms. It provides an easy-to-use platform, and some smart matching algorithms to…

Boundary Capital has introduced a ‘blended’ Fund that combines the benefits of SEIS and EIS to optimise potential returns for investors whilst also taking advantage of the tax breaks. Most investors who invest in private UK companies understand the benefits of investing in either EIS or SEIS funds. However there are two distinct advantages of…

Boundary Capital Partners LLP is authorised and regulated by the Financial Conduct Authority.
Boundary Capital Partners LLP Reg: OC387581 VAT: 204012873
Registered office: 35 Kingsland Road, London, England, E2 8AA

STAY CONNECTED WITH US: